Efficacy, Safety and Response Predictors of Astragalus Membranaceus on the Improvement of Cognitive Function in Mild-to-Moderate Alzheimer's Disease

PHASE2RecruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

July 30, 2025

Study Completion Date

July 30, 2025

Conditions
Alzheimer's Disease
Interventions
DRUG

10g Astragalus

Astragalus tablets 10g, warm water to drink, once a day, take for 1 year, during which routine treatment should also be carried out.

BEHAVIORAL

Routine treatment

Limit water and sodium intake. Raise the head of the bed. Standardized amount of exercise. Low temperature diet and small meals. Avoid alcohol, coffee and dehydration. The treatment lasted for 3 months.

DRUG

20g Astragalus

Astragalus tablets 20g, warm water to drink, once a day, take for 1 year, during which routine treatment should also be carried out.

Trial Locations (1)

350000

RECRUITING

Fujian Medical University Union Hospital, Fuzhou

All Listed Sponsors
lead

Fujian Medical University Union Hospital

OTHER